News & Updates

Cetuximab therapy appears to induce skin complications in patients following central venous port placement, reports a study.

A research team from the Faculty of Medicine, Chinese University of Hong Kong (CUHK) has identified molecular features in Epstein-Barr virus (EBV) DNA specifically associated with nasopharyngeal cancer (NPC) that differ significantly from the EBV DNA found in individuals with general EBV infections.

In the treatment of children hospitalized with pneumococcal meningitis, administering dexamethasone within 12 hours of initiating antibiotics appears reduce the 30-day risk of death, according to a retrospective study.

Taking vitamin D supplements does not appear to help reduce the risk of acute respiratory infections (ARIs) contrary to previous report, according to an updated meta-analysis.

Treatment with the acetylcholinesterase inhibitor donepezil hydrochloride falls short of improving post–COVID-19 conditions such as fatigue and psychological symptoms, as shown in a study from Japan.

In adults with virologically suppressed HIV-1* infection, switching to a two-drug regimen of doravirine 100 mg and islatravir 0.25 mg (DOR/ISL) was noninferior to continuing bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) or other baseline antiretroviral therapy (bART) regimens in maintaining viral suppression at 48 weeks, according to two phase III trials presented at CROI 2025.